Molnucen Molnupiravir 200 Mg
Price range: $60.00 through $210.00
| Quantity Value | Price | Quantity | Add To Cart |
|---|---|---|---|
| 160 Capsules | $210.00 |
|
|
| 40 Capsules | $60.00 |
|
|
| 80 Capsules | $115.00 |
|
SKU : N/A
Category : Viral Care
Molnucen Molnupiravir 200 mg is an oral antiviral medicine used to treat mild to moderate COVID-19 by reducing viral replication and helping lower the risk of hospitalization or severe disease. It is most effective when started within the first few days after symptom onset under medical supervision.
Molnucen Molnupiravir 200 mg
Molnucen Molnupiravir 200 mg is a prescription antiviral medication containing molnupiravir as its active ingredient. It is designed for the oral treatment of mild to moderate COVID-19 infection in adults who are at high risk of progressing to severe disease, hospitalization, or death. As a generic formulation of molnupiravir, Molnucen provides the same mechanism of action and therapeutic benefits as branded antiviral pills but often at a more accessible price.
How Molnucen Works
Molnucen Molnupiravir 200 mg is a prodrug of a synthetic nucleoside analogue that becomes active after being metabolized in the body. Once activated, it interferes with the replication of the SARS-CoV-2 virus, the virus that causes COVID-19, by incorporating into the viral RNA during replication. This leads to erroneous viral genetic material, which reduces the ability of the virus to multiply and spread. In effect, this lowers the viral load in the body and helps the immune system clear the infection more efficiently.
The drug’s antiviral action is most effective when started early in the course of infection — ideally within the first 5 days of symptom onset — because viral replication peaks in the first week of illness.
Primary Uses and Indications
Molnucen Molnupiravir 200 mg is indicated for:
-
Treatment of mild to moderate COVID-19 in adult patients
-
People at high risk of developing severe disease (elderly, immunocompromised, or those with underlying medical conditions like diabetes, cardiovascular disease, or chronic respiratory illness)
-
Adults who are not hospitalized but are at risk of progressing to more serious illness
It is not intended for use in patients who are already hospitalized with severe COVID-19, and it should not be used as a preventive (prophylactic) treatment for people exposed to the virus but not yet symptomatic.
Benefits of Molnucen Molnupiravir
The main benefits of Molnucen Molnupiravir 200 mg treatment include:
-
Reduced risk of hospital admission or death in high-risk COVID-19 patients when started early
-
Short treatment course, typically 5 days
-
Oral administration (pill form), which is convenient and accessible compared to intravenous antivirals
-
May help alleviate symptoms faster by reducing viral load
These advantages make Molnucen an important tool in outpatient COVID-19 management, particularly when other antiviral drugs or monoclonal antibodies are not available or suitable.
Dosage and Administration
The commonly prescribed regimen for molnupiravir is:
-
800 mg (4 capsules of 200 mg) taken twice daily
-
Duration: 5 days
-
Timing: Ideally started within five days of the first signs of COVID-19 symptoms
The capsules should be swallowed whole with water and may be taken with or without food. Patients should complete the full course even if they start feeling better before the 5 days are up.
Side Effects and Safety Information
Like all medications, Molnucen may cause side effects in some people. Commonly reported effects include:
-
Nausea
-
Diarrhoea
-
Dizziness
-
Headache
These side effects are generally mild and resolve as treatment ends. Rarely, allergic reactions or more serious symptoms may occur, and medical advice should be sought if unusual or persistent symptoms develop.
Precautions and Contraindications
Before starting Molnucen molnupiravir:
-
Inform your healthcare provider if you are pregnant or planning pregnancy — molnupiravir is not recommended during pregnancy due to potential risks.
-
Effective contraception is advised during treatment and for a short period afterward for women of childbearing potential, and for men with partners of childbearing potential.
-
Discuss any other medications you are taking to avoid interactions.
Molnupiravir is not recommended for use in children under 18 years due to lack of safety data and potential effects on bone and cartilage growth.
Storage and Handling
Store Molnucen Molnupiravir 200 mg in a cool, dry place below 30 °C, protected from light and moisture. Keep the medicine out of reach of children.
For medically reviewed information on molnupiravir and its role in treating COVID-19, visit the U.S. National Library of Medicine:
https://www.ncbi.nlm.nih.gov/books/NBK574519/
| Pack Size |
160 Capsules ,40 Capsules ,80 Capsules |
|---|
